Published in
Springer Nature [academic journals on nature.com], British Journal of Cancer, 7(124), p. 1222-1230, 2021
DOI: 10.1038/s41416-020-01229-1
Links
Tools
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis
Journal article published in 2021 by
Jesper van Breeschoten,
Michel W. J. M. Wouters,
Doranne L. Hilarius,
John B. Haanen,
Christian U. Blank,
Maureen J. B. Aarts,
Franchette W. P. J. van den Berkmortel,
Jan-Willem B. de Groot,
Geke A. P. Hospers,
Ellen Kapiteijn,
Djura Piersma,
Roos S. van Rijn,
Karijn P. M. Suijkerbuijk 
,
Willeke A. M. Blokx,
Bert-Jan J. ten Tije
and other authors.
,
Willeke A. M. Blokx,
Bert-Jan J. ten Tije
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 